blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2426142

EP2426142 - Modified vaccinia virus strains for use in a diagnostic and therapeutic method [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.09.2016
Database last updated on 31.08.2024
Most recent event   Tooltip02.09.2016Application deemed to be withdrawnpublished on 05.10.2016  [2016/40]
Applicant(s)For all designated states
Genelux Corporation
3030 Bunker Hill Street Suite 310
San Diego, California 92109 / US
[2012/10]
Inventor(s)01 / Frentzen, Alexa
1219 Hornblend St, Unit C
San Diego, CA 92109 / US
02 / Chen, Nanhai
9167 Buckwheat Street
San Diego, CA 92129 / US
03 / Zhang, Qian
12601 El Camino Real, Unit B
San Diego, CA 92130 / US
04 / Yu, Yong
3830 Elijah Ct, Unit 422
San Diego, CA 92130 / US
05 / Szalay, Aladar
7704 North Fork Road
Highland, CA California 92346 / US
 [2012/10]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2014/02]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Former [2012/10]Baldock, Sharon Claire
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date11183725.816.10.2007
[2012/10]
Priority number, dateUS20060852390P16.10.2006         Original published format: US 852390 P
US20070933050P04.06.2007         Original published format: US 933050 P
US20070950587P18.07.2007         Original published format: US 950587 P
US20070994794P21.09.2007         Original published format: US 994794 P
[2012/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2426142
Date:07.03.2012
Language:EN
[2012/10]
Type: A3 Search report 
No.:EP2426142
Date:13.06.2012
Language:EN
[2012/24]
Search report(s)(Supplementary) European search report - dispatched on:EP14.05.2012
ClassificationIPC:C07K14/54, C07K14/715, C12N7/04, C12N15/863, A61K35/76, A61K39/39, A61K48/00
[2012/10]
CPC:
C12N7/00 (EP,US); A61K31/282 (EP,US); A61K31/4745 (EP,US);
A61K31/7068 (EP,US); A61K33/241 (EP,US); A61K33/242 (EP,US);
A61K33/243 (EP,US); A61K33/244 (EP,US); A61K35/76 (US);
A61K38/1709 (EP,US); A61K38/1793 (EP,US); A61K38/20 (EP,US);
A61K38/204 (EP,US); A61K38/36 (EP,US); A61K38/484 (EP,US);
A61K39/12 (EP,US); A61K39/285 (EP,US); A61K39/3955 (US);
A61K45/06 (EP,US); A61K48/0058 (EP,US); A61K49/0008 (EP,US);
A61K49/0045 (EP,US); A61K49/0047 (EP,US); A61K49/0097 (EP,US);
A61K49/14 (EP,US); A61K49/1896 (EP,US); A61K51/00 (EP,US);
A61K9/0019 (EP,US); A61P31/00 (EP); A61P35/00 (EP);
A61P35/04 (EP); C07K14/005 (EP,US); C07K14/47 (US);
C07K14/54 (EP,US); C07K14/5412 (US); C07K14/7155 (US);
C07K16/22 (EP,US); C12N15/86 (EP,US); C12Q1/04 (EP,US);
G01N33/574 (EP,US); G01N33/585 (EP,US); A61K2039/523 (EP,US);
A61K2039/5254 (EP,US); A61K2039/5256 (EP,US); A61K48/00 (EP,US);
C07K2317/622 (EP,US); C07K2317/73 (EP,US); C07K2319/00 (US);
C07K2319/20 (EP,US); C07K2319/60 (EP,US); C07K2319/61 (EP,US);
C07K2319/74 (US); C12N2710/14171 (US); C12N2710/24121 (US);
C12N2710/24122 (EP,US); C12N2710/24132 (EP,US); C12N2710/24141 (US);
C12N2710/24143 (EP,US); C12N2710/24162 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/10]
Extension statesAL03.10.2011
BA03.10.2011
HR03.10.2011
MK03.10.2011
RS03.10.2011
TitleGerman:Modifizierte Impfstoffvirusstämme zur Verwendung in einem Diagnose- und Therapieverfahren[2012/10]
English:Modified vaccinia virus strains for use in a diagnostic and therapeutic method[2012/10]
French:Souches de virus de vaccin modifiées pour une utilisation pour le diagnostic et procédé thérapeutique[2012/10]
Examination procedure03.10.2011Examination requested  [2012/10]
12.12.2012Amendment by applicant (claims and/or description)
03.07.2013Despatch of a communication from the examining division (Time limit: M04)
13.11.2013Reply to a communication from the examining division
02.11.2015Communication of intention to grant the patent
03.05.2016Application deemed to be withdrawn, date of legal effect  [2016/40]
30.05.2016Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2016/40]
Parent application(s)   TooltipEP07872632.0  / EP2097517
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070872632) is  26.10.2009
Fees paidRenewal fee
03.10.2011Renewal fee patent year 03
03.10.2011Renewal fee patent year 04
03.10.2011Renewal fee patent year 05
24.10.2012Renewal fee patent year 06
08.04.2014Renewal fee patent year 07
27.10.2014Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.10.201307   M06   Fee paid on   08.04.2014
31.10.201509   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]FR2710536  (TRANSGENE SA [FR]) [A] 1-28* example 2 *;
 [YD]US2005031643  (SZALAY ALADAR A [US], et al) [YD] 1-28 * RVGL21 virus * * page 21, column 1, line 46 *;
 [X]  - SHIDA H ET AL, "EFFECTS AND VIRULENCES OF RECOMBINANT VACCINIA VIRUSES DERIVED FROMATTENUATED STRAINS THAT EXPRESS THE HUMAN T-CELL LEUKEMIA VIRUS TYPE I EVELOPE GENE", INTERVIROLOGY, KARGER, XX, (19881201), vol. 62, no. 12, ISSN 0300-5526, pages 4474 - 4480, XP001056061 [X] 1 * figure 1; table 1 *
 [YD]  - OZBEK S ET AL, "The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells", ONCOGENE, NATURE PUBLISHING GROUP, GB, (20010222), vol. 20, no. 8, doi:10.1038/SJ.ONC.1204180, ISSN 0950-9232, pages 972 - 979, XP002300404 [YD] 1-28 * abstract *

DOI:   http://dx.doi.org/10.1038/sj.onc.1204180
by applicantUS4215051
 US4603112
 US4722848
 US4769330
 US4912199
 US4980285
 US5110587
 US5174993
 US5364773
 US5631150
 US5683985
 US5693533
 US5707928
 US5710137
 US5712384
 US5719054
 US5750396
 US5759828
 US5888783
 US5919670
 US5922576
 US6261551
 US6265189
 US6319703
 US6429001
 US6455673
 US2003009015
 EP1281772
 EP1281767
 EP1281777
 US2003031681
 WO03014380
 US6548068
 US6573090
 US6589531
 US6596279
 US2003198627
 WO03104485
 US6713066
 US2004127446
 US6777220
 US6800288
 US6821956
 US2005031643
 US6924128
 US2005244428
 US6974695
 US2006099224
 US7045313
 US2006134801
 US2006159706
 US7112436
 US2007172455
    - BULLER, NATURE, (1985), vol. 317, pages 813 - 815
    - SHIDA ET AL., J. VIROL., (1988), vol. 62, no. 12, pages 4474 - 80
    - TAYLOR ET AL., J. GEN. VIROL., (1991), vol. 72, no. 1, pages 125 - 30
    - NOGRADY, Medicinal Chemistry A Biochemical Approach, OXFORD UNIVERSITY PRESS, (1985), pages 388 - 392
    - KOZAK, J. BIOL. CHEM., (1991), vol. 266, pages 19867 - 19870
    - SHINE, DELGARNO, NATURE, (1975), vol. 254, no. 5495, pages 34 - 38
    - CARILLO ET AL., SIAM J APPLIED MATH, (1988), vol. 48, page 1073
    - PEARSON, PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, page 2444
    - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
    - ATSCHUL, S.F., J. MOLEC. BIOL., (1990), vol. 215, page 403
    - CARILLO, SIAM J APPLIED MATH, (1988), vol. 48, page 1073
    - NEEDLEMAN ET AL., J. MOL. BIOL., (1970), vol. 48, page 443
    - SMITH, WATERMAN, ADV. APPL. MATH., (1981), vol. 2, page 482
    - GRIBSKOV, NUCL. ACIDS RES., (1986), vol. 14, page 6745
    - SCHWARTZ AND DAYHOFF,, Atlas of Protein Sequence and Structure, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, (1979), pages 353 - 358
    - WATSON ET AL., Molecular Biology of the Gene, 4th Edition, THE BENJAMIN/CUMMINGS PUB. CO., (1987), page 224
    - RIZZO, NAT BIOTECHNOL., (2004), vol. 22, no. 4, pages 445 - 9
    - WANG ET AL., PNAS US A, (2004), vol. 101, no. 48, pages 16745 - 9
    - NGUYEN, DAUGHERTY, NAT BIOTECHNOL., (2005), vol. 23, no. 3, pages 355 - 60
    - NAGAI ET AL., NAT. BIOTECHNOL., (2002), vol. 20, no. 1, pages 87 - 90
    - SHANER NC, STEINBACH PA, TSIEN RY., NAT METHODS., (2005), vol. 2, no. 12, pages 905 - 9
    - MATZ ET AL., NATURE BIOTECHNOLOGY, (1999), vol. 17, pages 969 - 973
    - BEVIS, GLICK, NAT. BIOTECHNOL., (2002), vol. 20, pages 83 - 87
    - SHKROB ET AL., BIOCHEM J., (2005), vol. 392, no. 3, pages 649 - 54
    - WIEDENMANN, PROC NATL ACAD SCI U S A., (2002), vol. 99, no. 18, pages 11646 - 51 1
    - MOSS, CURR. OPIN. GENET. DEV., (1993), vol. 3, pages 86 - 90
    - BRODER, EARL, MOL. BIOTECHNOL., (1999), vol. 13, pages 223 - 245
    - TIMIRYASOVA, BIOTECHNIQUES, (2001), vol. 31, pages 534 - 540
    - PATEL ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 9431 - 9435
    - DAVISON, MOSS, J MOL BIOL, (1989), vol. 210, pages 749 - 769
    - DAVISON ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, pages 4285 - 4286
    - CHAKRABARTI ET AL., BIOTECHNIQUES, (1997), vol. 23, pages 1094 - 1097
    - CHAKRABARTI ET AL., BIO TECHNIQUES, (1997), vol. 23, no. 6, pages 1094 - 1097
    - AL'TSHTEIN ET AL., DOKL. AKAD. NAUK USSR, (1983), vol. 285, pages 696 - 699
    - SMITH ET AL., ADV EXP MED BIOL., (1998), vol. 440, pages 395 - 414
    - VANDERPLASSCHEN ET AL., PROC NATL ACAD SCI U S A., (1998), vol. 95, no. 13, pages 7544 - 9
    - SMITH ET AL., IMMUNOL REV., (1997), vol. 159, pages 137 - 54
    - VANDERPLASSCHEN ET AL., J GEN VIROL., (1997), vol. 78, no. 8, pages 2041 - 8
    - BLASCO, J VIROL., (1993), vol. 67, no. 6, pages 3319 - 25
    - VANDERPLASSCHEN ET AL., PROC NATL ACAD SCI USA., (1998), no. 13, pages 7544 - 9
    - ROPER, R.L., J. VIROL., (2006), vol. 80, no. 1, pages 306 - 313
    - DE WET ET AL., MOL. CELL. BIOL., (1987), vol. 7, pages 725 - 737
    - LORENZ ET AL., PNAS USA, (1991), vol. 88, pages 4438 - 4442
    - WOOD ET AL., SCIENCE, (1989), vol. 244, no. 4905, pages 700 - 2
    - PRASHER ET AL., GENE, (1987), vol. 111, pages 229 - 233
    - MATZ, NATURE BIOTECHNOLOGY, (1999), vol. 17, pages 969 - 973
    - OSBORN ET AL., MOL. THER., (2005), vol. 12, pages 569 - 74
    - DAVIDSON ET AL., CANCER RES., (2005), vol. 65, pages 4663 - 4672
    - VITALITI, CANCER RESEARCH, (2000), vol. 60, pages 4311 - 4314
    - OZBEK ET AL., ONCOGENE, (2001), vol. 20, no. 8, pages 972 - 979
    - FANG ET AL., J. VIROL., (1997), vol. 71, no. 6, pages 4798 - 4803
    - BLANCOU, 1. VIROL., (2004), vol. 78, no. 3, pages 1080 - 1092
    - HE ET AL., PNAS U S A, (1998), vol. 95, no. 5, pages 2509 - 2514
    - RACANIELLO ET AL., SCIENCE, (1981), vol. 214, pages 916 - 919
    - RAJU ET AL., J. VIROL., (1991), vol. 65, no. 5, pages 2501 - 2510
    - LATCHMAN ET AL., NUCL. ACIDS RES., (1989), vol. 17, no. 21, pages 8533 - 8541
    - HSUE, MASTERS, J. VIROL., (1999), vol. 73, no. 7, pages 6128 - 6135
    - FOLEY ET AL., GENES & DEV., (1992), vol. 6, pages 730 - 744
    - KEEGAN ET AL., SCIENCE, (1986), vol. 231, pages 699 - 704
    - DAVISON, MOSS, J. MOL. BIOL., (1989), vol. 210, pages 749 - 769
    - DAVISON, MOSS, J. MOL. BIOL., (1989), vol. 210, pages 771 - 784
    - WEIR, MOSS, J. VIROL., (1987), vol. 61, no. 1, pages 75 - 80
    - BROYLES ET AL., J. BIOL. CHEM., (1999), vol. 274, no. 50, pages 35662 - 35667
    - BROYLES, J. GEN. VIROL., (2003), vol. 84, pages 2293 - 2903
    - KNUTSON ET AL., J. VIROL., (2006), vol. 80, no. 14, pages 6784 - 6793
    - CHAKRABARTI ET AL., BIOTECHNIQUES, (1997), vol. 23, no. 6, pages 1094 - 1097
    - DAVISON, MOSS, NUC. ACIDS RES., (1990), vol. 18, no. 14, pages 4285 - 4286
    - HAMMOND ET AL., J. VIROL. METH., (1997), vol. 66, pages 135 - 138
    - KUMAR, BOYLE, VIROLOGY, (1990), vol. 179, pages 151 - 158
    - BALDICK ET AL., J. VIROL., (1992), vol. 66, pages 4710 - 4719
    - WITTEK ET AL., CELL, (1980), vol. 21, pages 487 - 493
    - BROYLES, MOSS, PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 3141 - 3145
    - AHN ET AL., MOL. CELL. BIOL., (1990), vol. 10, pages 5433 - 54441
    - BROYLES, PENNINGTON, J. VIROL., (1990), vol. 64, pages 5376 - 5382
    - KATZ ET AL., J. VIROLOGY, (2003), vol. 77, pages 12266 - 12275
    - MOORE ET AL., EMBO J., (1992), vol. 11, pages 1973 - 1980
    - KOTWAL ET AL., VIROLOGY, (1989), vol. 171, pages 579 - 587
    - CHILD ET AL., VIROLOGY., (1990), vol. 174, pages 625 - 629
    - LEE ET AL., J VIROL., (1992), vol. 66, pages 2617 - 2630
    - ISAACS ET AL., PROC NATL ACAD SCI USA., (1992), vol. 89, pages 628 - 632
    - COUPAR ET AL., J. GEN. VIROL., (2000), vol. 81, pages 431 - 439
    - SMITH ET AL., VACCINE, (1993), vol. 11, no. 1, pages 43 - 53
    - BARR ET AL., BIOCHIM. ET BIOPHYS. ACTA, (2002), vol. 1577, pages 337 - 353
    - KRISHNAMURTHY, VIROLOGY, (2000), vol. 278, no. 1, pages 168 - 182
    - OSBORN ET AL., MOL THER., (2005), vol. 12, no. 3, pages 569 - 74
    - MICHIENZI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 99, no. 22, pages 14047 - 14052
    - TOMITA ET AL., INTERNTL. 1. MOL. MED., (2004), vol. 13, pages 629 - 636
    - CHO-CHUNG, MOL. CELL. BIOCHEM., (2000), vol. 212, no. 1-2, pages 29 - 34
    - SEKI ET AL., MOL. CANER THER., (2006), vol. 5, pages 985 - 994
    - BROYLES, METHODS MOL BIOL., (2004), vol. 269, pages 135 - 142
    - WRIGHT, METHODS MOL. BIOL., (2004), vol. 269, pages 143 - 150
    - NOVELLINO, CANCER IMMUNOL IMMUNOTHER., (2005), vol. 54, no. 3, pages 187 - 207
    - EISENBERGER ET AL., HEMATOL ONCOL CLIN NORTH AM., (2006), vol. 20, no. 3, pages 661 - 87
    - AGHA-MOHAMMADI, LOTZE, J. CLIN. INVEST., (2000), vol. 105, no. 9, pages 1177 - 1183
    - BELAS, SCIENCE, (1982), vol. 218, pages 791 - 793
    - FORAN, BROWN, NUCLEIC ACIDS RES., (1988), vol. 16, page 177
    - PRASHER ET AL., BIOCHEM., (1987), vol. 26, pages 1326 - 1332
    - ESCHER ET AL., PNAS, (1989), vol. 86, pages 6528 - 6532
    - CONTAG ET AL., MOL. MICROBIOL., (1995), vol. 18, pages 593 - 603
    - WU ET AL., PNAS USA, (2002), vol. 97, pages 8495 - 8500
    - LEWIS ET AL., 1. MED. CHEM., (1999), vol. 42, pages 1341 - 1347
    - ADONAI ET AL., PNAS USA, (2002), vol. 99, pages 3030 - 3035
    - LEENDERS ET AL., J. NEURAL. TRANSM. SUPPL., (1994), vol. 43, pages 123 - 132
    - CALONDER ET AL., J. NEUROCHEM., (1999), vol. 73, pages 2047 - 2055
    - BESHARA ET AL., BR. J. HAEMATOL., (1999), vol. 104, pages 288 - 295,296-302
    - AKITA ET AL., CANCER SCI., (2006), vol. 97, no. 10, pages 1075 - 1081
    - KHALIL ET AL., CHEMBIOCHEM., (2006), vol. 7, no. 4, pages 678 - 683
    - DAVISON, MOSS, J MOI BIOL, (1989), vol. 210, pages 749 - 769
    - DAVISON, NUCLEIC ACIDS RES., (1990), vol. 18, pages 4285 - 4286
    - ZIMMERMANN ET AL., NEURON, (1994), vol. 12, pages 11 - 24
    - VIDAL ET AL., EMBO J., (1990), vol. 9, pages 833 - 840
    - MAYFORD ET AL., CELL, (1995), vol. 81, pages 891 - 904
    - PINKERT ET AL., GENES & DEV., (1987), vol. 1, pages 268 - 76
    - TIMIRYASOVA ET AL., BIOTECHNIQUES, (2001), vol. 31, pages 534 - 540
    - RATHINAVELU ET AL., CANCER BIOCHEM. BIOPHYS., (1999), vol. 17, pages 133 - 146
    - WANG ET AL., 1. INVEST. DERMATOL., (2006), vol. 126, pages 1372 - 1377
    - BROYLES, 1. GEN. VIROL, (2003), vol. 84, pages 2293 - 2303
    - ROSALES, PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 3794 - 3798
    - WRIGHT ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 40680 - 40686
    - DELLIS ET AL., VIROLOGY, (2004), vol. 329, no. 2, pages 328 - 336
    - SLEZAK ET AL., VIRUS RES., (2004), vol. 102, no. 2, pages 177 - 184
    - OH, BROYLES, J. VIROL., (2005), vol. 79, no. 20, pages 12852 - 12860
    - SHI ET AL., BIOCHIM. BIOPHYS. ACTA, (1997), vol. 1332, pages F49 - F66
    - CHEN ET AL., J. VIROL., (1991), vol. 66, pages 4303 - 4314
    - BELL ET AL., VIROLOGY, (1998), vol. 252, pages 149 - 161
    - BAUKNECHT ET AL., EMBO J., (1992), vol. 11, pages 4607 - 4617
    - PAJUNNK ET AL., J. GEN. VIROL., (1997), vol. 78, pages 3287 - 3295
    - MARTELLI ET AL., J. VIROL., (1996), vol. 70, pages 1433 - 1438
    - ZOCK ET AL., J. VIROL., (1993), vol. 67, pages 682 - 693
    - MOMOEDA ET AL., J. VIROL., vol. 68, pages 7159 - 7168
    - KNOSSI, J. VIROL., (1999), vol. 73, pages 1254 - 1261
    - KATO ET AL., J. VIROL. METHODS, (2004), vol. 115, no. 1, pages 31 - 40
    - CHILD ET AL., VIROLOGY, (1990), vol. 174, pages 625 - 629
    - LEE ET AL., J. VIROL., (1992), vol. 66, pages 2617 - 2630
    - ISAACS ET AL., PROC. NATL. ACAD. SCI. USA., (1992), vol. 89, pages 628 - 632
    - MIKRYUKOV ET AL., BIOTEKHNOLOGIYA, (1988), vol. 4, pages 442 - 449
    - MIKRYUKOV ET AL., BIOTEKHNOLOGIY, (1988), vol. 4, pages 442 - 449
    - GOEBEL ET AL., VIROLOGY, (1990), vol. 179, pages 247 - 266
    - VEIJOLA ET AL., 1. BIOL. CHEM., (1994), vol. 269, pages 26746 - 26753
    - BARRETT, BIOLOGICALS, (1997), vol. 25, pages 17 - 25
    - MCALLISTER ET AL., J. VIROL., (2000), vol. 74, pages 9197 - 9205
    - MURPHY ET AL., VIRUS RES., (1994), vol. 32, pages 13 - 26
    - YU ET AL., MOL GENET GENOMICS, (2002), vol. 268, pages 169 - 178
    - EARL ET AL., SCIENCE, (1986), vol. 234, pages 728 - 831
    - LATHE ET AL., NATURE (LONDON, (1987), vol. 32, pages 878 - 880
    - BERNARDS ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 6854 - 6858
    - ESTIN ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 1052 - 1056
    - KANTOR ET AL., J. NATL. CANCER INST., (1992), vol. 84, pages 1084 - 1091
    - ROTH ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 4781 - 4786
    - RAO ET AL., J. IMMUNOL., (1996), vol. 156, pages 3357 - 3365
    - CHAMBERLAIN ET AL., CANCER RES., (1996), vol. 56, pages 2832 - 2836
    - OERTLI ET AL., J. GEN. VIROL., (1996), vol. 77, pages 3121 - 3125
    - CHATTERJEE, HUMAN GENE THER., (1996), vol. 7, pages 1853 - 1860
    - MCANENY ET AL., ANN. SURG. ONCOL., (1996), vol. 3, pages 495 - 500
    - BLUMENREICH, CANCER, (1985), vol. 55, no. 5, pages 1118 - 1122
    - FORASTIERE, J. CLIN. ONCOL., (2001), vol. 19, no. 4, pages 1088 - 1095
    - NAGASE ET AL., CANCER TREAT. REP., (1987), vol. 71, no. 9, pages 825 - 829
    - THEON ET AL., 1. AM. VET. MED. ASSOC., (1993), vol. 202, no. 2, pages 261 - 7
    - MCINTOSH ET AL., J. VIROL., (1996), vol. 70, page 272081
    - FALKNER, MOSS, J. VIROL., (1990), vol. 64, pages 3108 - 2111
    - CHAKRABARTI ET AL., MOL. CELL BIOL., (1985), vol. 5, pages 3403 - 3409
    - HORTON ET AL., METHODS ENZYMOL., (1993), vol. 217, pages 270 - 279
    - MOSS, EARL, CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, (1998), page 16.17.4
    - FALKNER, MOSS, 1. VIROL., (1990), vol. 64, pages 3108 - 3111
    - BLASCO ET AL., J. VIROL., (1993), vol. 67, pages 3319 - 3325
    - ZHANG ET AL., CANCER RESEARCH, (2007), vol. 67, no. 20
    - WANG ET AL., J. INVEST. DERMATOL., (2006), vol. 126, pages 1372 - 1377
 US20030163763
 EP20010118417
 EP20010125911
 EP20020012552
 US20020189918
 EP20020794632
 EP20030013826
 EP20030018478
 EP20030024283
 US20040849664
 US20040866606
 US20040872156
 WO2004US19866
 US20050238025
 US20070827518
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.